| Literature DB >> 19285551 |
Valerian E Kagan1, Hülya A Bayir, Natalia A Belikova, Olexandr Kapralov, Yulia Y Tyurina, Vladimir A Tyurin, Jianfei Jiang, Detcho A Stoyanovsky, Peter Wipf, Patrick M Kochanek, Joel S Greenberger, Bruce Pitt, Anna A Shvedova, Grigory Borisenko.
Abstract
Recently, phospholipid peroxidation products gained a reputation as key regulatory molecules and participants in oxidative signaling pathways. During apoptosis, a mitochondria-specific phospholipid, cardiolipin (CL), interacts with cytochrome c (cyt c) to form a peroxidase complex that catalyzes CL oxidation; this process plays a pivotal role in the mitochondrial stage of the execution of the cell death program. This review is focused on redox mechanisms and essential structural features of cyt c's conversion into a CL-specific peroxidase that represent an interesting and maybe still unique example of a functionally significant ligand change in hemoproteins. Furthermore, specific characteristics of CL in mitochondria--its asymmetric transmembrane distribution and mechanisms of collapse, the regulation of its synthesis, remodeling, and fatty acid composition--are given significant consideration. Finally, new concepts in drug discovery based on the design of mitochondria-targeted inhibitors of cyt c/CL peroxidase and CL peroxidation with antiapoptotic effects are presented.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19285551 PMCID: PMC2732771 DOI: 10.1016/j.freeradbiomed.2009.03.004
Source DB: PubMed Journal: Free Radic Biol Med ISSN: 0891-5849 Impact factor: 7.376